Wireless News - LDR Spine Gets FDA Approval to Conduct Clinical Trial for a Second- Generation Cervical Artificial Disc
January 12th, 2009Wireless News
02-01-2006
LDR Spine Gets FDA Approval to Conduct Clinical Trial for a Second- Generation Cervical Artificial Disc
WIRELESS NEWS-February 1, 2006-LDR Spine Gets FDA Approval to Conduct…
Medical Marketing and Media - Bextra woes boost rivals as treatment options narrow
January 5th, 2009THE PAINKILLER Mobic saw sharp gains in new users in the days following Pfizer’s withdrawal of COX-2 drug Bextra.
In the week ending April 8, nearly 25 percent of former Bextra patients switched to Mobic, which is jointly marketed by Abbott Laboratories and Boehringer Ingelheim, according to data from Verispan’s Vector One.
Bear Stearns analyst Rick Wise said in published repo…
Chain Drug Review - Boehringer Ingelheim’s Mobic receives FDA clearance
January 2nd, 2009Related Results
MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article
> The Food and Drug Administration has approved the use of Mobic as a treatment for rheumatoid arthritis. Boehringer Ingelheim Inc. launched the drug four years ago for treating osteoarthritis, the most comm…
Internal Medicine News - Generic versions of osteoarthritis drug
December 30th, 2008The Food and Drug Administration has approved the first generic versions of Mobic (meloxicam) for the treatment of osteoarthritis. The new approvals of 13 generic meloxicam applications stem from the agency’s cluster review approach, aimed at increasing efficiency and decreasing review time for generic drugs.
Related Results
MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article
In the case of meloxicam, …
Running & FitNews - New arthritis drug - Mobic - Brief Article - Product Announcement
December 26th, 2008The real breakthrough was when the COX-2 inhibiting nonsteroidal anti-inflammatory drugs (NSAIDs) first emerged. First was Celebrex. Next came Vioxx. Now there is Mobic (or meloxicam) for the treatment of the symptoms of osteoarthritis. For those who suffer chronic arthritis pain, these drugs were a true innovation. The first generation of NSAIDs…
Australasian Business Intelligence - Popular drugs danger warning.
December 23rd, 2008Jun 26, 2005 (The Mercury - ABIX via COMTEX)
Related Results
MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article
Concerns are being raised about some of the most commonly used medicines in Australia. The arthritis drug Vioxx was withdrawn from sale in 2004, because trials indicated an increased risk of heart attack and s…
FDA Consumer - Generic drugs for osteoarthritis
December 20th, 2008 The FDA has approved several generic versions of Boehringer Ingelheim’s Mobic (meloxicam) tablets. Meloxicam is indicated for the treatment of osteoarthritis.
“This is another example of our agency’s endeavor to counter rising health care costs by approving safe and effective generic alternatives to brand name drugs,” Gary Buehler, director of the FDA’s Office of Generic Drugs (OGD), said in announcing the July 2006 approval. “Meloxicam is a widely-…
What You Can Do If You Have Arthritis Knee Pain… Information From An Expert
December 15th, 2008The most common type of arthritis is osteoarthritis (OA). This article discusses the diagnosis and management of this common problem.
Osteoarthritis (OA) of the knee is one of the most common causes of knee pain in people over the age of 30. The cause is progressive wearing away of the cartilage cushion that covers the ends of the long bones that make up the knee joint. The inflammation that accompanies this process…
Is The Fox Guarding The Henhouse?
December 10th, 2008About WebMD
WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. WebMD is a subsidiary of Emdeon Corporation (Nasdaq: HLTH). The WebMD Health Network reaches approximately 30 million visitors a month through its leading owned and operated health sites t…
Drug Store News - Arthritis: direct medical costs reach $51 billion
December 3rd, 2008 The latest figures show that roughly 43 million American adults–about 1-in-5–have arthritis diagnosed by a doctor, making it the leading cause of disability in the United States. This number is projected to increase to 67 million by 2030.
Each yea…


